C. Bart Rountree

Bone marrow fails to differentiate into liver epithelium during murine development and regeneration.

A CD133-expressing murine liver oval cell population with bilineage potential.

Fibroblast growth factor 10 is critical for liver growth during embryogenesis and controls hepatoblast survival via beta-catenin activation.

Expansion of liver cancer stem cells during aging in methionine adenosyltransferase 1A-deficient mice.

Expansion of CD133-expressing liver cancer stem cells in liver-specific phosphatase and tensin homolog deleted on chromosome 10-deleted mice.

CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis.

Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta.

Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion.

Expansion of hepatic tumor progenitor cells in Pten-null mice requires liver injury and is reversed by loss of AKT2.

Clinical application for the preservation of phospho-proteins through in-situ tissue stabilization.

Stem cells in drug discovery, regenerative medicine and cancer.

c-Met represents a potential therapeutic target for personalized treatment in hepatocellular carcinoma.

Regression of established hepatocellular carcinoma is induced by chemoimmunotherapy in an orthotopic murine model.

Snail1 induces epithelial-to-mesenchymal transition and tumor initiating stem cell characteristics.

Stem cells in liver diseases and cancer: recent advances on the path to new therapies.